Advertisement
Screener

Arena Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

Arena Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

Arena Pharmaceuticals, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$353.09 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2021-02-23

  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-12-31 was -$61.43M.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-09-30 was -$52.42M.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-06-30 was -$55.11M.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-03-31 was $737.65M.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2020 was -$353.09M, a 162.09% decline from fiscal 2019.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2019 was $568.69M.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2018 was -$131.88M.
  • Arena Pharmaceuticals, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$63.79M.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filedNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filedNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filedNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed
2020-12-31-$353.09M
10-K · filed 2021-02-23
2019-12-31-$61.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
-$113.84M
derived: sum of 2 quarters · filed 2021-02-23
-$168.96M
derived: sum of 3 quarters · filed 2021-02-23
$568.69M
10-K · filed 2021-02-23
2019-09-30-$52.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$107.53M
derived: sum of 2 quarters · filed 2019-11-08
$630.12M
10-Q · filed 2019-11-08
$596.40M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30-$55.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$682.54M
10-Q · filed 2019-08-09
$648.82M
derived: sum of 3 quarters · filed 2021-02-23
$618.06M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$737.65M
10-Q · filed 2019-05-09
$703.93M
derived: sum of 2 quarters · filed 2021-02-23
$673.17M
derived: sum of 3 quarters · filed 2021-02-23
$634.95M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31-$33.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
-$64.48M
derived: sum of 2 quarters · filed 2021-02-23
-$102.70M
derived: sum of 3 quarters · filed 2021-02-23
-$131.88M
10-K · filed 2021-02-23
2018-09-30-$30.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$68.98M
derived: sum of 2 quarters · filed 2019-11-08
-$98.16M
10-Q · filed 2019-11-08
-$105.38M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$38.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$67.40M
10-Q · filed 2019-08-09
-$74.63M
derived: sum of 3 quarters · filed 2020-02-27
-$93.84M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$29.18M
10-Q · filed 2019-05-09
-$36.41M
derived: sum of 2 quarters · filed 2020-02-27
-$55.62M
derived: sum of 3 quarters · filed 2020-02-27
-$80.64M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$7.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$26.44M
derived: sum of 2 quarters · filed 2020-02-27
-$51.46M
derived: sum of 3 quarters · filed 2020-02-27
-$63.79M
10-K · filed 2020-02-27
2017-09-30-$19.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$44.23M
derived: sum of 2 quarters · filed 2018-11-08
-$56.56M
10-Q · filed 2018-11-08
-$60.49M
10-Q · filed 2017-11-08
-$74.39M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$25.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$37.36M
10-Q · filed 2018-08-07
-$42.19M
10-Q · filed 2017-08-08
-$55.18M
derived: sum of 3 quarters · filed 2019-02-28
-$74.88M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$12.34M
10-Q · filed 2018-05-09
-$16.26M
10-Q · filed 2017-05-09
-$30.16M
derived: sum of 2 quarters · filed 2019-02-28
-$49.86M
derived: sum of 3 quarters · filed 2019-02-28
-$66.05M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$17.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$37.53M
derived: sum of 2 quarters · filed 2019-02-28
-$53.71M
derived: sum of 3 quarters · filed 2019-02-28
-$71.29M
10-K · filed 2019-02-28
-$62.14M
10-K · filed 2017-03-15
2016-09-30-$19.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$35.89M
derived: sum of 2 quarters · filed 2017-11-08
-$53.47M
10-Q · filed 2017-11-08
-$77.22M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$16.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$33.77M
10-Q · filed 2017-08-08
-$57.52M
derived: sum of 3 quarters · filed 2018-03-14
-$83.78M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31-$17.58M
10-Q · filed 2017-05-09
-$41.33M
derived: sum of 2 quarters · filed 2018-03-14
-$67.59M
derived: sum of 3 quarters · filed 2018-03-14
-$91.56M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$23.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$50.01M
derived: sum of 2 quarters · filed 2018-03-14
-$73.98M
derived: sum of 3 quarters · filed 2018-03-14
-$96.99M
10-K · filed 2018-03-14
-$98.11M
10-K · filed 2017-03-15
2015-09-30-$26.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$50.22M
derived: sum of 2 quarters · filed 2016-11-09
-$73.24M
10-Q · filed 2016-11-09
-$95.64M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30-$23.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$46.98M
10-Q · filed 2016-08-09
-$69.39M
derived: sum of 3 quarters · filed 2017-03-15
-$95.34M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31-$23.02M
10-Q · filed 2015-05-11
-$45.42M
derived: sum of 2 quarters · filed 2017-03-15
-$71.38M
derived: sum of 3 quarters · filed 2017-03-15
-$105.30M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31-$22.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$48.36M
derived: sum of 2 quarters · filed 2017-03-15
-$82.28M
derived: sum of 3 quarters · filed 2017-03-15
-$101.40M
10-K · filed 2017-03-15
2014-09-30-$25.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
-$59.88M
derived: sum of 2 quarters · filed 2014-11-06
-$78.99M
10-Q · filed 2014-11-06
-$33.47M
derived: sum of 4 quarters · filed 2015-05-11
2014-06-30-$33.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
-$53.03M
10-Q · filed 2014-08-06
-$7.51M
derived: sum of 3 quarters · filed 2015-05-11
-$5.72M
derived: sum of 4 quarters · filed 2015-05-11
2014-03-31-$19.12M
10-Q · filed 2015-05-11
$26.40M
derived: sum of 2 quarters · filed 2015-05-11
$28.20M
derived: sum of 3 quarters · filed 2015-05-11
2013-12-31$45.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$47.32M
derived: sum of 2 quarters · filed 2015-03-02
$72.80M
10-K · filed 2015-03-02
2013-09-30$1.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$27.28M
10-Q · filed 2014-11-06
2013-06-30$25.48M
10-Q · filed 2014-08-06
2012-12-31-$44.05M
10-K · filed 2015-03-02